
Centre Hospitalier Universitaire De Nice
- Address
- 4 Avenue Reine Victoria
Sponsor Overview
Specializations
Haematology and Acute Myeloid Leukemia
Clinical research includes treatment strategies for acute myeloid leukemia, with interest in remission depth, genomic risk, and response assessment using minimal residual disease markers.
- Acute Myeloid Leukemia
- Deep remission
- Minimal residual disease
- Genomic stratification
The sponsor also supports work in treatment adaptation and biomarker-guided monitoring in haematologic malignancy care.
Dermatology and Inflammatory Skin Disease
Research activity spans psoriasis, vitiligo, acne, lichen planus, lichen planopilaris, epidermolysis bullosa, and other epidermal genodermatoses, with attention to immune-mediated skin inflammation and pigmentary disorders.
- Psoriasis
- Vitiligo
- Acne
- Epidermolysis bullosa
- Lichen planus
Studies also address superficial basal cell carcinoma and severe inherited keratinisation disorders, reflecting a broad dermatology portfolio.
Rheumatology, Osteoarthritis and Pain
Work in musculoskeletal disease covers rheumatoid arthritis, erosive osteoarthritis, thumb osteoarthritis, and severe acute pain, with focus on symptom control and structural joint outcomes.
- Rheumatoid arthritis
- Erosive osteoarthritis
- Trapezometacarpal osteoarthritis
- Severe acute pain
Additional interest extends to inflammatory joint disease management and pain-relieving interventions in degenerative hand conditions.
Nephrology and Metabolic Disease
Clinical studies include membranous nephropathy, extramembranous glomerulonephritis, and kidney involvement in type 2 diabetes, with attention to proteinuria, renal impairment, and immune activity in glomerular disease.
- Membranous nephropathy
- Extramembranous glomerulonephritis
- Type 2 diabetes with renal impairment
- Proteinuria
Research also includes obesity and metabolic regulation in patients with complex renal and endocrine profiles.
Infectious Disease, Neurology and Other Specialised Areas
The sponsor funds studies in prosthetic joint infections, osteoarticular infections, generalized periodontitis, migraine, progressive multiple sclerosis, and facioscapulohumeral muscular dystrophy.
- Prosthetic joint infections
- Migraine with aura
- Progressive multiple sclerosis
- Facioscapulohumeral muscular dystrophy
- Periodontal disease
Additional research covers diabetic keto-acidosis and rare oncology-related care such as choroid melanoma managed with proton therapy.
Sponsored Trials
Data & Insights
This sponsor works with 43 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 88 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases10 trials247 other sponsors
- 2.Bacterial Infections and Mycoses3 trials180 other sponsors
- 3.Musculoskeletal Diseases3 trials238 other sponsors
- 4.Nervous System Diseases3 trials449 other sponsors
- 5.Not possible to specify2 trials220 other sponsors
- 6.Therapeutics2 trials87 other sponsors
- 7.Anesthesia and Analgesia1 trial100 other sponsors
- 8.Eye Diseases1 trial138 other sponsors
- 9.Hormonal diseases1 trial89 other sponsors
- 10.Immune System Diseases1 trial322 other sponsors
- 11.Neoplasms1 trial853 other sponsors
- 12.Nutritional and Metabolic Diseases1 trial211 other sponsors
- 13.Virus Diseases1 trial182 other sponsors
Partnered Research Centres
88 centres- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- 149 Rue De Sevres, 75015 Paris
- Address
- 3 Boulevard Alexandre Fleming, 25000 Besançon
- Address
- 14 rue ernest Hemingway immeuble saphir, 97200 Fort De France
- Address
- 159 rue du fbg Poissonnière, 75009 Paris
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Centre Hospitalier Universitaire De Nice.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

